Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma.
Curr Oncol Rep
; 25(9): 989-996, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-37266890
Full text:
1
Database:
MEDLINE
Main subject:
Melanoma
/
Neoplasm Recurrence, Local
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Curr Oncol Rep
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article
Affiliation country:
France